Javier Ramon Archives - Institute for Bioengineering of Catalonia

September 18, 2023

European funding for the treatment of Type 1 diabetes using 3D bioprinting

IBEC researcher Javier Ramón Azcón has been awarded an “ERC Proof of Concept Grant.” This prestigious funding is granted by the European Research Council to explore the commercial and societal potential of research projects conducted in European institutions. Ramón’s project, Uniink, is centered on the treatment of Type 1 diabetes using cell therapy and 3D bioprinting.

April 24, 2023

IBEC researcher James Eills to meet with Nobel laureates

Dr. James Eills, researcher at IBEC, has been selected to attend the prestigious Lindau Nobel Laureate Meeting that brings together outstanding young scientists from around the world with Nobel laureates. … Read more

November 21, 2022

Scientific summit to fight against neuromuscular diseases

Juanma Fernandez

Scientists and patients meet at the IBEC to look for new treatment strategies for these minority pathologies. The journal Ara interviewed Juanma Fernandez Costa, postdoc researcher at the group of … Read more

November 14, 2022November 14, 2022

Researchers develop a “gym on a chip” that will help to study diabetes and find new drugs to treat the disease

Coinciding with World Diabetes Day, researchers from the Institute for Bioengineering of Catalonia (IBEC) reveal a study that combines muscle and pancreatic cells on a single chip and demonstrates that … Read more

April 26, 2022March 25, 2022

Bioengineering to treat diabetes in the media

<img width="500" height="333" src="https://ibecbarcelona.eu/wp-content/uploads/2022/04/senior-woman-makes-blood-glucose-test-1.jpg" class="attachment-full size-full wp-post-image" alt="" decoding="async" itemprop="image" srcset="https://ibecbarcelona.eu/wp-content/uploads/2022/04/senior-woman-makes-blood-glucose-test-1.jpg 500w, https://ibecbarcelona.eu/wp-content/uploads/2022/04/senior-woman-makes-blood-glucose-test-1-300x200.jpg 300w" sizes="(max-width: 500px) 100vw, 500px" />

Researchers from the Institute for Bioengineering of Catalonia (IBEC) led by ICREA Research Professor Javier Ramón, appear in the media for a recent study in collaboration with IDIBAPS researchers, in which they have developed small spheres capable of responding to variations in the levels glucose and produce insulin in vitro.

April 4, 2022March 17, 2022

Innovative bioengineered spheres might help treating diabetes

<img width="500" height="333" src="https://ibecbarcelona.eu/wp-content/uploads/2022/04/senior-woman-makes-blood-glucose-test-1.jpg" class="attachment-full size-full wp-post-image" alt="" decoding="async" itemprop="image" srcset="https://ibecbarcelona.eu/wp-content/uploads/2022/04/senior-woman-makes-blood-glucose-test-1.jpg 500w, https://ibecbarcelona.eu/wp-content/uploads/2022/04/senior-woman-makes-blood-glucose-test-1-300x200.jpg 300w" sizes="(max-width: 500px) 100vw, 500px" />

Researchers from IBEC, in collaboration with IDIBAPS in Barcelona, have developed nontoxic small spheres able to respond to variations in glucose levels, and producing insulin in vitro. These biomimetic spheroids containing pancreatic β-cells were prepared based on 3D bioprinting. This approach might help in the future improving clinical outcomes of β-cell transplantation strategies for diabetes treatment, as well as for in vitro drug screening platforms.

November 4, 2021November 3, 2021

14th IBEC Symposium brings international experts and 300 attendees together

International experts and three hundred registered attendees met in the 14th IBEC Symposium, dedicated to regenerative therapies. Organised by the Institute for Bioengineering of Catalonia (IBEC), speakers presented the latest advances in mini-organs, organs on a chip, 3D bioprinting and tissue engineering, among others.

November 2, 2021

New biosensor detects inflammatory marker in muscle with high sensitivity

In a recent publication in the journal Nanophotonics, IBEC researchers present a new biosensor for the direct and sensitive detection of the protein interleukin-6 in muscle, an indicator of inflammation and potential disease, proving the high performance of the device on bioengineered 3D skeletal muscles. This new approach may result in a promising tool for measuring the efficacy of drug candidates for diseases where inflammation is present such as muscular dystrophy.

May 6, 2021April 30, 2021

Towards a treatment for myotonic dystrophy: the first 3D model with patient cells

IBEC researchers led by Javier Ramón and Juan M. Fernández develop the first three-dimensional model for myotonic dystrophy, a rare disease that currently has no cure. The model combines patient cells and bioengineering techniques and represents a major advance over the use of animals and cell cultures. This new model will help in the design of personalized and more effective treatments, and for drug testing in a much more efficient way.

January 26, 2021January 8, 2021

Two IBEC projects granted by “Knowledge Industry Call” of the Catalan Government

A project led by Elisabeth Engel aimed to fabricate and test a dressing prototype for wound healing, and another project led by Javier Ramón with the goal of developing an artificial liver, have been granted by the Knowledge Industry Programme of the Catalan Government.